IMCR: Immunocore Holdings plc - ADR Company Profile & Statistics

About

Immunocore Holdings plc is a late-stage biotechnology company. It engages in development of a novel class of T cell receptor bispecific immunotherapies designed to treat diseases, including cancer, infectious and autoimmune disease. Immunocore Holdings plc is based in Abingdon, the United Kingdom.

Info & Links

CEO

Bahija Jallal

Headquarters

92 PARK DRIVE, MILTON PARK, ABINGDON
OXFORDSHIRE, X0 OX14 4RY, UNITED KINGDOM

Auditor

KPMG LLP

Share holders

Employees

497

Immunocore Holdings plc - ADR Statistics

Valuation Measures

Market Capitalization²

1.51B

Enterprise Value

1.42B

Enterprise Value/EBITDA(ttm)

-22.13

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.78

Price to Book(mrq)

3.75

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

99.14%

Operating Margin(ttm)

-15.87%

Profit Margin(ttm)

-16.83%

Return on Equity(ttm)

-12.84%

Return on Invested Capital(ttm)

-8.06%

Return on Assets(ttm)

-5.09%

Income Statement

Revenue(ttm)

296.31M

Revenue Per Share(ttm)

5.92

Gross Profit(ttm)

293.71M

EBITDA(ttm)³

-63.99M

Net Income Available to Common(ttm)

-47.05M

Diluted EPS(ttm)

-0.95

Share Statistics

Beta (5Y Monthly)

0.73

52-Week Change

-41.74%

S&P 500 52-Week Change

26.27%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

50.03M

Dividend Yield

0.00%

Float⁴

45.48M

% Held by Insiders

9.10%

% Held by Institutions

84.50%

Balance Sheet

Total Cash(mrq)

901.28M

Total Cash Per Share(mrq)

18.01

Total Debt(mrq)

438.69M

Total Debt/Equity(mrq)

116.11%

Current Ratio(mrq)

3.78%

Quick Ratio(mrq)

3.76%

Book Value Per Share(mrq)

7.55

Cash Flow

Operating Cash Flow Per Share(ytd)

0.76

Free Cash Flow(ytd)

38.42M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IMCR

Immunocore Holdings plc - ADR

Immunocore Holdings plc - ADR Profile